How do you evaluate the strategies that Merck and Pfizer have pursued in light of the changing industry structure? How well have Merck and Pfizer responded to these changes in industry structure? Have they improved or weakened the firm's positions with respect to that structure?
This is from the following case study: Strategy in the Twenty-First Century Pharmaceutical
Industry: Merck & Co. and Pfizer Inc.